Search Within

Rachel Kobos

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Pediatric Leukemia (7)
  4. Pediatrics, Department of (7)
  5. Population Sciences Research Program (7)
  6. Hematologic Malignancies Service (5)

More Groups

People
  1. Neerav Shukla (5)
  2. Alex Kentsis (3)
  3. Kevin Curran (3)
  4. Michael Walsh (3)
  5. Peter Steinherz (3)
  6. Alison Moskowitz (2)

More People

Years
  1. 2020 (1)
  2. 2016 (5)
  3. 2015 (1)
Publications
  1. Pediatric Blood and Cancer (2)
  2. Blood (1)
  3. Bone Marrow Transplantation (1)
  4. Haematologica (1)
  5. Lancet Oncology (1)
  6. The Oncologist (1)
Publishers
  1. Wiley Periodicals, Inc (2)
  2. American Society of Hematology (1)
  3. Elsevier Science, Inc. (1)
  4. Ferrata Storti Foundation (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II multicenter, open-label study of oral ENMD-2076 for the treatment of patients with advanced fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Mayer, R.; Venook, A. P.; O'Neill, A. F.; Beg, M. S.; LaQuaglia, M.; Kingham, P. T.; Kobos, R.; Basturk, O.; Brennan, C.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling for improved diagnosis and therapy of pediatric acute leukemias
    Meeting Abstract

    Kobos, R.; He, J.; Steinherz, P. G.; Curran, K. J.; Renaud, T. M.; Forlenza, C.; Boulad, F.; Prockop, S.; Knapp, K. M.; Walsh, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors
    Journal Article

    Praveen, A.; Friedman, D. N.; Sklar, C.; Oeffinger, K.; Castiel, M.; Kearney, J.; Singh, B.; Prockop, S. E.; Kernan, N. A.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Integrating genomics onto clinical pediatric oncology using the molecular tumor board at the Memorial Sloan Kettering Cancer Center
    Journal Article

    Ortiz, M. V.; Kobos, R.; Walsh, M.; Slotkin, E. K.; Roberts, S.; Berger, M. F.; Hameed, M.; Solit, D.; Ladanyi, M.; Shukla, N.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save